Integrated BioSci Investing

INTEGRATED BIOSCI INVESTING MEMBERSHIP FEATURES:

✓ IBI Long-Term Core Portfolio

CP-Alpha portfolio features 30 stocks recommendation focusing on various therapeutic areas such as CAR-T, infectious disease, NASH, and immuno-oncology.

✓ All-inclusive portfolio

It tracks the developments of over 70 bioscience stocks under coverage.

✓ Alpha Intelligence research

Once-weekly Integrated BioSci best ideas in the form of a report, research, or an expert interview.

✓ Daily Integrated BioSci analysis

High-level intelligence published in advance of free articles.

✓ M&A Series

Forecasts potential M&A prospects using IBI's five criteria. 

✓ Specialty Report Series

In-depth analysis of a particular niche and leading innovators.

✓ Educational Series

Teaches new investors while reinforces profitable investing philosophies and techniques to seasoned experts.

✓ Competitive Intelligence Report

Covers key developments centering highly promising bioscience stocks plus the competitiveness of their lead molecule versus competitors.

✓ Market Moving Report

Provides insight regarding catalysts moving a particular stock with corresponding strategies to capture profits.

✓ Notable Community Discussion

Summarizes actionable ideas shared by community members.

✓ Industry Trends

Analysis of emerging industry trends to help investors capture "early bird" profits.

✓ Expert Interviews

Features insight from other experts as well as company executives via interview.

✓ Coverage

Regular portfolio updates and quarterly reviews.

✓ Consults

Direct communication with the author to answer your questions.

✓ Chats

Live access to a community of doctors, scientists, professional analysts, fund managers, and everyday investors.